17 pending office actions • 6 clients • 15 examiners • 8 art units • 0 of 17 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 9 (53%) |
| §102 only | 3 (18%) |
| §112 only | 2 (12%) |
| No statute on record | 3 (18%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLDBERG, JEANINE ANNE | 2 | 46.0% | +40.4% |
| LAFAVE, ELIZABETH ROSE | 2 | 55.3% | +56.3% |
| PIHONAK, SARAH | 1 | 60.9% | +43.4% |
| KOVACH, KARA NICOLE | 1 | 100.0% | +0.0% |
| WORSHAM, JESSICA N | 1 | 56.6% | +57.0% |
| WOOLWINE, SAMUEL C | 1 | 61.0% | +20.0% |
| HAVLIN, ROBERT H | 1 | 52.3% | +27.2% |
| PARISI, JESSICA DANIELLE | 1 | 79.8% | +28.0% |
| WILDER, CYNTHIA B | 1 | 70.9% | +26.6% |
| LU, FRANK WEI MIN | 1 | 63.0% | +66.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18549884 | CHEMICAL SAMPLE INDEXING FOR HIGH-THROUGHPUT SINGLE-CELL ANALYSIS | KOVACH, KARA NICOLE | 7d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 126d overdue |
| 17751023 | METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION | LAFAVE, ELIZABETH ROSE | 121d overdue |
| 17957386 | SELECTIVE EXTENSION IN SINGLE CELL WHOLE TRANSCRIPTOME ANALYSIS | WILDER, CYNTHIA B | 42d overdue |
| 18251528 | MULTIPLEX DETECTION OF BACTERIAL RESPIRATORY PATHOGENS | GOLDBERG, JEANINE ANNE | 28d overdue |
| 18568160 | EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER | PIHONAK, SARAH | 26d overdue |
| 17923506 | COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES | LAFAVE, ELIZABETH ROSE | 15d |
| 18261213 | PHARMACEUTICAL COMPOSITIONS COMPRISING ACALABRUTINIB | WORSHAM, JESSICA N | 27d |
| 18187488 | OLIGONUCLEOTIDES ASSOCIATED WITH ANTIBODIES | WOOLWINE, SAMUEL C | 41d |
| Client (Assignee) | Pending OAs |
|---|---|
| BECTON, DICKINSON AND COMPANY | 8 |
| SINGLERON (NANJING) BIOTECHNOLOGIES, LTD. | 3 |
| NATCO PHARMA LIMITED | 2 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2 |
| Singleron Biotechnologies Inc. | 1 |
| CELLULAR RESEARCH, INC. | 1 |
| Art Unit | Apps |
|---|---|
| 1684 | 5 |
| 1681 | 4 |
| 1682 | 3 |
| 1627 | 1 |
| 1615 | 1 |
| 1626 | 1 |
| 1683 | 1 |
| 1635 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18568160 | EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER | Natco Pharma Limited | PIHONAK, SARAH | 1627 | §103 | Non-Final OA | 26d overdue | Pending | Dec 07, 2023 |
| 18549884 | CHEMICAL SAMPLE INDEXING FOR HIGH-THROUGHPUT SINGLE-CELL ANALYSIS | Singleron (Nanjing) Biotechnologies, Ltd. | KOVACH, KARA NICOLE | 1681 | §103 | Non-Final OA | 7d | Pending | Sep 08, 2023 |
| 18261213 | PHARMACEUTICAL COMPOSITIONS COMPRISING ACALABRUTINIB | Natco Pharma Limited | WORSHAM, JESSICA N | 1615 | Other | Final Rejection | 27d | Pending | Jul 12, 2023 |
| 18251528 | MULTIPLEX DETECTION OF BACTERIAL RESPIRATORY PATHOGENS | BECTON, DICKINSON AND COMPANY | GOLDBERG, JEANINE ANNE | 1682 | §103 | Non-Final OA | 28d overdue | Pending | May 02, 2023 |
| 18251147 | A METHOD FOR SINGLE-CELL NASCENT RNA LABELING AND SEQUENCING | Singleron (Nanjing) Biotechnologies, Ltd. | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | 61d | Pending | Apr 28, 2023 |
| 18187488 | OLIGONUCLEOTIDES ASSOCIATED WITH ANTIBODIES | BECTON, DICKINSON AND COMPANY | WOOLWINE, SAMUEL C | 1681 | §112 | Final Rejection | 41d | Pending | Mar 21, 2023 |
| 18058216 | METHODS AND COMPOSITIONS FOR COMBINATORIAL BARCODING | BECTON, DICKINSON AND COMPANY | HAVLIN, ROBERT H | 1626 | Other | Final Rejection | 54d | Pending | Nov 22, 2022 |
| 17923506 | COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES | Pacific Biosciences of California, Inc. | LAFAVE, ELIZABETH ROSE | 1684 | §102 | Non-Final OA | 15d | Pending | Nov 04, 2022 |
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | Singleron (Nanjing) Biotechnologies, Ltd. | PARISI, JESSICA DANIELLE | 1684 | §103 | Non-Final OA | 126d overdue | Pending | Oct 13, 2022 |
| 17957386 | SELECTIVE EXTENSION IN SINGLE CELL WHOLE TRANSCRIPTOME ANALYSIS | BECTON, DICKINSON AND COMPANY | WILDER, CYNTHIA B | 1681 | §103 | Final Rejection | 42d overdue | Pending | Sep 30, 2022 |
| 17822948 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | BECTON, DICKINSON AND COMPANY | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | 71d | Pending | Aug 29, 2022 |
| 17751023 | METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION | Singleron Biotechnologies Inc. | LAFAVE, ELIZABETH ROSE | 1684 | §102 | Non-Final OA | 121d overdue | Pending | May 23, 2022 |
| 17575094 | SURFACE STRUCTURING WITH COLLOIDAL ASSEMBLY | Pacific Biosciences of California, Inc. | FLINDERS, JEREMY C | 1684 | §102 | Final Rejection | 31d overdue | Pending | Jan 13, 2022 |
| 17373653 | cDNA SPIKE-IN CONTROL FOR SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY | YU, TIAN NMN | 1681 | §103 | Final Rejection | 51d overdue | Pending | Jul 12, 2021 |
| 17174249 | INTRACELLULAR ABSEQ | BECTON, DICKINSON AND COMPANY | SHIN, DANA H | 1635 | §103 | Final Rejection | 9d | Pending | Feb 11, 2021 |
| 17151058 | METHODS AND COMPOSITIONS FOR SINGLE CELL SECRETOMICS | BECTON, DICKINSON AND COMPANY | SISSON, BRADLEY L | 1682 | Other | Final Rejection | 14d | Pending | Jan 15, 2021 |
| 16551620 | SAMPLE MULTIPLEXING USING CARBOHYDRATE-BINDING AND MEMBRANE-PERMEABLE REAGENTS | Cellular Research, Inc. | BUNKER, AMY M | 1684 | §103 | Final Rejection | 19d | Pending | Aug 26, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial